Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.52
Delayed Data
As of Feb 27
 -0.02 / -3.70%
Today’s Change
0.40
Today|||52-Week Range
0.93
-7.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues489.0K0.000.000.00
 
 
Depreciation And Amortization19.8K37.6K90.0K39.5K
 
 
 
 
 
 
Operating ExpensesGross Income469.1K-37.6K-90.0K-39.5K
 
 
 
 
 
General Expenses9.0M12.9M15.6M21.4M
 
 
 
 
 
Research And Development3.7M5.8M8.1M12.9M
 
 
 
 
 
Total Operating Expenses9.0M13.0M15.7M21.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.5M-13.0M-15.7M-21.5M
 
 
 
 
 
Extraordinary Credit0.000.0069.6K0.00
 
 
Extraordinary Charge0.00-410.9K0.00-79.6K
 
 
 
Interest Expense On Debt1.6K0.000.000.00
 
 
Other Expenses-2.5K60.4K-5.0K-1.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.5M-13.3M-15.6M-21.5M
 
 
 
 
 
Preferred Dividend-5.6M0.000.000.00
 
 
Net Income-8.5M-13.3M-15.6M-21.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS13.2M28.2M47.6M76.6M
 
 
 
 
 
Shares To Calculate EPS Diluted13.2M28.2M47.6M76.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.07-$0.47-$0.33-$0.28
 
 
 
 
 
EPS Diluted-$1.07-$0.47-$0.33-$0.28
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account